85-1405-79　HIV-2 gp36, Recombinant (Human Immunodeficiency Virus-2) discontinued 1mg　H6009-03A

特徴

• An E. coli-derived recombinant protein that composes all of the reported immunogenic determinants found in gp36. The gene encoding this fusion protein was synthesized using codons optimized for E. coli expression and doesn't represent a linear HIV-II envelope sequence. rHIV-II is a non-glycosylated, 135 aa polypeptide chain, having a molecular mass of 16,127D, P.I 5.17.
• Biological Activity:This antigen was thoroughly tested in various tests as well as ELISA using the standard BBI serum panels & 3 gp39-specific monoclonal antibodies. All antibody detection tests on this antigen were as sensitive or more than the standard Abott third generation tests.
• Solubility: rHIV-II is soluble in water and most aqueous buffers below and above the isoelectric point (pI 5)
• Storage and Stability:Store at 4°C. Stable for at least 12 months. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

• Size：1mg
• Source Antigen：Recombinant from E. coli
• Grade：Highly Purified
• Purity：≥ 97.0% as determined by RP-HPLC, Anion-exchange FPLC and SDS-PAGE.
• Form：Supplied as a liquid in 6M urea.
• Calc Applications Abbrev：E
• EU Commodity Code：30021019
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]